PPTA Twitter

PlasmaProteins
PlasmaProteins The continued production of #plasmaprotein therapies depends on reliable, healthy, repeat donors. Millions of #plasma donations are necessary to treat PPT-dependent individuals each year. Learn why your donation matters from @BatesWhiteEcon : bit.ly/2Bqbitk
About 16 hours ago.
PlasmaProteins
PlasmaProteins Approximately how many #plasma donation centers are there in the U.S.?
2 days ago.

PPTA Presents in Malta

During the biannual Plasma Product Biotechnology Meeting held 15-19 May in Malta, PPTA was invited to make two presentations:

"The World Needs Plasma from the USA and Other Countries" described the importance of U.S. plasma for the manufacturing of plasma protein therapies in the world, the need to remove restrictions on Source plasma collections in other countries and a better use of recovered plasma to meet patient needs.

"Source Plasma Safety" addressed the various steps in donor screening and the value of Source Industry standards for Qualified donors, Inventory hold, and viral marker rates. Residual risk of a window period donation entering the manufacturing pool was discussed. as well as the effectiveness of viral inactivation/ removal were also presented.

Both presentations are available on our website.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100